Home » News » Awards & Advancement » GENFIT names Larue executive VP, biomarkers

GENFIT names Larue executive VP, biomarkers

Wednesday, October 19, 2011

GENFIT, a biopharmaceutical company, has named Dr. Catherine Larue executive vice-president, biomarkers.

Before joining GENFIT, Larue spent eleven years within the Bio-Rad group, where she occupied various management positions, ranging from an R&D department to the direction of a business unit.

“We are delighted by the arrival of Catherine Larue at GENFIT. Her experience, particularly in development, and her dynamic nature will enable us to significantly intensify our biomarker activity, for which our principal research programs are advancing rapidly and for which we expect to have numerous commercial prospects,” said Jean-François Mouney, CEO & chairman of GENFIT’s management board.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!